Kodak gets massive state-backing from the Trump administration to manufacture generic drugs inhouse and reduce its dependency on sourcing APIs from China. From making camera lenses to making drugs, Eastman Kodak is all set to be back in the market! On Wednesday, July 29, Eastman Kodak Company (NYSE: KODK) stock saw a massive rally jumping over 300% in a single day. The massive Kodak stock rally comes as U.S. President Donald Trump announced a complete makeover of the company to now being a pharmaceutical producer. On Tuesday, the Trump administration…
KODK Stock Up 300%, Trump Grants $765M to Kodak Pharmaceuticals
